AR061484A1 - Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar - Google Patents
Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviarInfo
- Publication number
- AR061484A1 AR061484A1 ARP070102645A ARP070102645A AR061484A1 AR 061484 A1 AR061484 A1 AR 061484A1 AR P070102645 A ARP070102645 A AR P070102645A AR P070102645 A ARP070102645 A AR P070102645A AR 061484 A1 AR061484 A1 AR 061484A1
- Authority
- AR
- Argentina
- Prior art keywords
- antigen
- genes
- formulation
- amino acid
- acid sequences
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229960005486 vaccine Drugs 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 206010022000 influenza Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- 108091035707 Consensus sequence Proteins 0.000 abstract 1
- 101710082439 Hemagglutinin A Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81424106P | 2006-06-16 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061484A1 true AR061484A1 (es) | 2008-08-27 |
Family
ID=38834237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102645A AR061484A1 (es) | 2006-06-16 | 2007-06-15 | Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8163876B2 (enExample) |
| EP (1) | EP2029167A4 (enExample) |
| JP (1) | JP2009540801A (enExample) |
| KR (1) | KR20090027216A (enExample) |
| CN (1) | CN101472607A (enExample) |
| AR (1) | AR061484A1 (enExample) |
| AU (1) | AU2007261196A1 (enExample) |
| BR (1) | BRPI0713671A2 (enExample) |
| CA (1) | CA2654178A1 (enExample) |
| WO (1) | WO2007149715A2 (enExample) |
| ZA (1) | ZA200808845B (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1833030B (zh) | 2003-05-22 | 2014-07-23 | 美国弗劳恩霍夫股份有限公司 | 用于表达、传递及纯化目标多肽的重组载体分子 |
| EP1919504B1 (en) | 2005-08-03 | 2013-10-16 | iBio, Inc. | Antibody to bacillus anthracis protective antigen |
| JP2009540801A (ja) * | 2006-06-16 | 2009-11-26 | ダウ・アグロサイエンス・エル・エル・シー | トリインフルエンザ赤血球凝集素の新規なｄｎａ配列、ベクターおよびタンパク質 |
| EP2092059A4 (en) | 2006-10-24 | 2012-03-28 | Bogoch Samuel | METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES |
| MX2009013091A (es) | 2007-05-30 | 2010-07-30 | Bogoch Samuel | Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura. |
| US8404252B2 (en) | 2007-07-11 | 2013-03-26 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
| EP2300493A2 (en) * | 2008-04-23 | 2011-03-30 | Samuel Bogoch | Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| DK2318530T3 (en) * | 2008-07-18 | 2016-10-03 | Medicago Inc | Ny epitope to immunization against influenza |
| US20120034253A1 (en) * | 2008-09-25 | 2012-02-09 | Fraunhofer Usa, Inc. | Influenza Vaccines, Antigens, Compositions, and Methods |
| WO2010037046A1 (en) | 2008-09-28 | 2010-04-01 | Fraunhofer Usa, Inc. | Humanized neuraminidase antibody and methods of use thereof |
| US9233148B2 (en) | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
| EP2421546A1 (en) * | 2009-04-23 | 2012-02-29 | Samuel Bogoch | Replikin-sequences for preventing/treating influenza and determining infectivity/lethality |
| US8784819B2 (en) | 2009-09-29 | 2014-07-22 | Ibio Inc. | Influenza hemagglutinin antibodies, compositions and related methods |
| CN101693894B (zh) * | 2009-10-15 | 2011-07-27 | 北京大学深圳研究生院 | 禽流感病毒h5n1假病毒及其制备方法与专用dna片段 |
| AR083533A1 (es) * | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
| CA2842345A1 (en) | 2011-07-20 | 2013-01-24 | Samuel Bogoch | Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| RU2682752C2 (ru) * | 2011-09-30 | 2019-03-21 | Медикаго Инк. | Повышение выхода вирусоподобных частиц в растениях |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| RU2531235C2 (ru) | 2013-02-15 | 2014-10-20 | Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") | Поливалентная вакцина против гриппа на основе гибридного белка |
| WO2015048129A1 (en) * | 2013-09-24 | 2015-04-02 | CHOI, Duk, Kyung | Avian influenza virus polypeptides and methods of their use |
| WO2017083627A1 (en) | 2015-11-13 | 2017-05-18 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| CA3015347A1 (en) | 2016-02-24 | 2017-08-31 | Visterra, Inc. | Formulations of antibody molecules to influenza virus |
| GB2578163A (en) * | 2018-10-19 | 2020-04-22 | Univ Pretoria | Plant produced avian influenza antigens and their uses in diagnostic assays and devices |
| EP3946613A1 (en) | 2019-03-25 | 2022-02-09 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| US20240191245A1 (en) * | 2021-03-18 | 2024-06-13 | Calyxt, Inc. | Plant cell matrices and methods thereof |
| CA3230289A1 (en) * | 2021-08-30 | 2023-03-09 | Japan Eco-Science Co., Ltd. | Immunostimulatory preparation and cosmetic, food, feed additive, and quasi-pharmaceutical product containing the immunostimulatory preparation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060035596A (ko) * | 2003-05-05 | 2006-04-26 | 보이스 톰슨 인스터튜트 포 플랜트 리서치 | 외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포 |
| WO2005116260A2 (en) * | 2004-05-25 | 2005-12-08 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
| JP2009535306A (ja) | 2006-04-21 | 2009-10-01 | ダウ・アグロサイエンス・エル・エル・シー | 鳥インフルエンザに対するワクチンおよび使用方法 |
| JP2009540801A (ja) * | 2006-06-16 | 2009-11-26 | ダウ・アグロサイエンス・エル・エル・シー | トリインフルエンザ赤血球凝集素の新規なｄｎａ配列、ベクターおよびタンパク質 |
-
2007
- 2007-06-08 JP JP2009515579A patent/JP2009540801A/ja active Pending
- 2007-06-08 BR BRPI0713671-4A2A patent/BRPI0713671A2/pt not_active IP Right Cessation
- 2007-06-08 KR KR1020087031047A patent/KR20090027216A/ko not_active Ceased
- 2007-06-08 CA CA002654178A patent/CA2654178A1/en not_active Abandoned
- 2007-06-08 EP EP07784373A patent/EP2029167A4/en not_active Withdrawn
- 2007-06-08 AU AU2007261196A patent/AU2007261196A1/en not_active Abandoned
- 2007-06-08 CN CNA2007800223807A patent/CN101472607A/zh active Pending
- 2007-06-08 WO PCT/US2007/070755 patent/WO2007149715A2/en not_active Ceased
- 2007-06-08 US US12/299,404 patent/US8163876B2/en not_active Expired - Fee Related
- 2007-06-15 AR ARP070102645A patent/AR061484A1/es not_active Application Discontinuation
-
2008
- 2008-10-16 ZA ZA200808845A patent/ZA200808845B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007261196A1 (en) | 2007-12-27 |
| WO2007149715A2 (en) | 2007-12-27 |
| US20090106864A1 (en) | 2009-04-23 |
| ZA200808845B (en) | 2009-10-28 |
| CA2654178A1 (en) | 2007-12-27 |
| BRPI0713671A2 (pt) | 2013-12-03 |
| KR20090027216A (ko) | 2009-03-16 |
| CN101472607A (zh) | 2009-07-01 |
| EP2029167A4 (en) | 2010-06-16 |
| US8163876B2 (en) | 2012-04-24 |
| WO2007149715A3 (en) | 2008-07-24 |
| JP2009540801A (ja) | 2009-11-26 |
| EP2029167A2 (en) | 2009-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007149715A3 (en) | Novel dna sequences, vectors and proteins of avian influenza hemagglutinin | |
| JP6957580B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| Lim et al. | Recent advances, approaches and challenges in the development of universal influenza vaccines | |
| ES2741729T3 (es) | Vectores y construcciones de liberación de antígenos de virus de la gripe | |
| Isakova-Sivak et al. | Influenza vaccine: Progress in a vaccine that elicits a broad immune response | |
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| AR109196A1 (es) | Métodos y composiciones para la expresión génica en plantas | |
| AR124928A2 (es) | Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteína c mutada y usos de la misma | |
| MX2024015050A (es) | L-asparaginasa modificada | |
| BRPI0815578B8 (pt) | Peptídeo de cdca1, seu uso e composição imunogênica compreendendo o mesmo para induzir imunidade, tratar e/ou prevenir o câncer, bem como método in vitro para induzir uma célula apresentadora de antígeno e uma célula t citotóxica (killer) | |
| CO6260151A2 (es) | Peptido de cdh3 y agente medicinal que comprende al mismo | |
| IL288541B (en) | Vaccine against rsv | |
| JP2009540801A5 (enExample) | ||
| EA033386B1 (ru) | Рекомбинантные иммуногенные полипептиды стеблевого домена гемагглютинина вируса гриппа а и их применение | |
| MX2012002216A (es) | Nueva endolisina obpgplys. | |
| AR079114A1 (es) | Proteinas de enlace de antigenos anti-orai1 y usos de las mismas | |
| CA3207612A1 (en) | Composite antigenic sequences and vaccines | |
| NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
| NZ598605A (en) | Vaccine against african horse sickness virus | |
| SA520420568B1 (ar) | جين متماثل من الديسموتاز فائق الأكسيد المستقر واستخداماته (sod) | |
| AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| PE20121171A1 (es) | Metodo, kit, plasmido y composicion para inducir una respuesta inmunitaria contra el virus del dengue basandose en vacunas de adn y virus quimericos | |
| Cargnelutti et al. | Development of a universal CTL-based vaccine for influenza | |
| BR112017014737A2 (pt) | formulação de peptídeos inibidores de mk2 | |
| Shi et al. | Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |